ID   Ishikawa 1-D-9
AC   CVCL_W423
DR   cancercelllines; CVCL_W423
DR   Wikidata; Q54898286
RX   DOI=10.1007/978-4-431-53981-0_2;
RX   PubMed=9183638;
CC   Population: Japanese.
CC   Doubling time: 35.0 hours (PubMed=9183638).
CC   Sequence variation: Mutation; HGNC; 8979; PIK3R1; Simple; p.Leu570Pro (c.1709T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 9177; POLE; Simple; p.Pro102Ser (c.304C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 9177; POLE; Simple; p.Asn751fs (c.2252delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 9588; PTEN; Simple; p.Glu288fs*3 (c.863delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 9588; PTEN; Simple; p.Thr319fs*1 (c.950_953delTACT) (p.VL317fs) (V317fs*3); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Asp49His (c.145G>C); ClinVar=VCV000135948; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Met246Val (c.736A>G); ClinVar=VCV000100815; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2529 ! Ishikawa
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 10
//
RX   DOI=10.1007/978-4-431-53981-0_2;
RA   Nishida M.;
RT   "Ishikawa cells: opening of in vitro hormone research on endometrial
RT   carcinoma.";
RL   (In) Cell and molecular biology of endometrial carcinoma; Kuramoto H., Nishida M. (eds.); pp.35-58; Springer; Tokyo (2003).
//
RX   PubMed=9183638;
RA   Nishida M., Kasahara K., Oki A., Satoh T., Arai Y., Kubo T.;
RT   "Establishment of eighteen clones of Ishikawa cells.";
RL   Hum. Cell 9:109-116(1996).
//